Ms. Harrington previously led the cardiovascular and orthopedic research and development initiatives within the company. In her new role, she will be involved in all operational aspects for the Frantz Medical Group of companies, and will serve as advisor for tactical and strategic input on the company’s biosciences seed initiatives.
Read the release on Stephanie Harrington’s promotion at Frantz Medical Group.
Related Articles on Executive Changes at Device Companies:
Symmetry Medical Appoints Former DePuy Orthopaedics President Thomas J. Sullivan As President and CEO
Orthofix Appoints Vicente Trelles as Senior VP
Wright Medical Group Appoints 3 New Executives Amid Internal Compliance Investigation
